- Home
- PRGO vs CATY Comparison
PRGO vs CATY Comparison
Compare PRGO & CATY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGO
- CATY
- Stock Information
- Founded
- PRGO 1887
- CATY 1962
- Country
- PRGO Ireland
- CATY United States
- Employees
- PRGO N/A
- CATY N/A
- Industry
- PRGO Biotechnology: Pharmaceutical Preparations
- CATY Major Banks
- Sector
- PRGO Health Care
- CATY Finance
- Exchange
- PRGO Nasdaq
- CATY Nasdaq
- Market Cap
- PRGO 4.0B
- CATY N/A
- IPO Year
- PRGO 1991
- CATY N/A
- Fundamental
- Price
- PRGO $27.48
- CATY $42.52
- Analyst Decision
- PRGO Buy
- CATY Hold
- Analyst Count
- PRGO 3
- CATY 5
- Target Price
- PRGO $33.00
- CATY $50.80
- AVG Volume (30 Days)
- PRGO 2.1M
- CATY 350.0K
- Earning Date
- PRGO 05-06-2025
- CATY 04-21-2025
- Dividend Yield
- PRGO 4.21%
- CATY 3.20%
- EPS Growth
- PRGO N/A
- CATY N/A
- EPS
- PRGO N/A
- CATY 3.95
- Revenue
- PRGO $4,373,400,000.00
- CATY $692,219,000.00
- Revenue This Year
- PRGO $3.49
- CATY $14.71
- Revenue Next Year
- PRGO $2.36
- CATY $7.53
- P/E Ratio
- PRGO N/A
- CATY $10.76
- Revenue Growth
- PRGO N/A
- CATY N/A
- 52 Week Low
- PRGO $23.14
- CATY $33.88
- 52 Week High
- PRGO $33.46
- CATY $55.29
- Technical
- Relative Strength Index (RSI)
- PRGO 56.66
- CATY 28.31
- Support Level
- PRGO $27.05
- CATY $43.73
- Resistance Level
- PRGO $28.15
- CATY $45.07
- Average True Range (ATR)
- PRGO 1.01
- CATY 1.19
- MACD
- PRGO 0.10
- CATY -0.36
- Stochastic Oscillator
- PRGO 49.94
- CATY 5.91
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.